Development and validation of a prognostic index for efficacy evaluation and prognosis of first-line chemotherapy in stage III–IV lung squamous cell carcinoma

OBJECTIVES: To establish a pre-therapy prognostic index model (PIM) of the first-line chemotherapy aiming to achieve accurate prediction of time to progression (TTP) and overall survival among the patients diagnosed with locally advanced (stage III) or distant metastasis (stage IV) lung squamous cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jiangdian, Tian, Jie, Zhang, Lina, Qu, Xiujuan, Qian, Wei, Zheng, Bin, Zhao, Jia, Niu, Meng, Zhou, Mu, Cui, Lei, Liu, Yunpeng, Zhao, Mingfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Chest
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443600/
https://www.ncbi.nlm.nih.gov/pubmed/30643941
http://dx.doi.org/10.1007/s00330-018-5912-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443600/
https://www.ncbi.nlm.nih.gov/pubmed/30643941
http://dx.doi.org/10.1007/s00330-018-5912-2

Ejemplares similares